PA
BLFS icon

Pineridge Advisors’s BioLife Solutions BLFS Stock Holding History

Pineridge Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26
Closed -$651 – 639
2024
Q3 		$651 Hold
26
– – ﹤0.01% 525
2024
Q2 		$557 Hold
26
– – ﹤0.01% 568
2024
Q1 		$482 Sell
26
-410
-94% -$7.17K ﹤0.01% 558
2023
Q4 		$7.08K Buy
+436
New +$5.56K ﹤0.01% 434

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pineridge Advisors's BLFS Position: Q4 2024 in Review

Pineridge Advisors sold out of BioLife Solutions (BLFS) in Q4 2024, closing a stake of 26 shares — an estimated $651 sold.

Pineridge Advisors first reported a position in BLFS in Q4 2023 and held it in 4 quarters. The position peaked at $7.08K in Q4 2023. 180 funds tracked by Wall St. Rank hold BLFS as of Q4 2024.

  • Pineridge Advisors reported no remaining BioLife Solutions position as of Q4 2024 after selling out during the quarter.
  • Pineridge Advisors sold 26 BioLife Solutions shares in Q4 2024, an estimated $651.
  • Pineridge Advisors first reported a position in BioLife Solutions in Q4 2023 and held it in 4 quarters.
  • Pineridge Advisors's BioLife Solutions position peaked at $7.08K in Q4 2023.
  • 180 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2024.

Based on Pineridge Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.